Dan Zandberg, MD

UPMC
Pittsburgh, PA

Disclosures:

  • Employment: UPMC Hillman Cancer Center:Associate Professor of Medicine:Employee
  • Compensation: Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Ongoing ;Glaxo Smith Kline (GSK): Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 3/9/2023 ;Seagen: Consultant, Research Grants, Research Funding, Research Salary Support,Compensation Payment-End Date: current ;BMS: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: current ;Merck: Grant Research Funding-E
  • Ownership: none
  • Leadership: none

Presentations

Sep 29

The Role of Systemic Therapy for Locally Recurrent Squamous Cell Carcinoma of the Head & Neck in the Setting of Prior Radiation Therapy
Room 310-312
05:17pm - 05:32pm PT